Movement Disorders — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-26.

Also called: Movement, Parkinson's & movement neurology. A 1–2 year fellowship entered after a neurology residency, not a residency you match into from medical school. Organ system: the nervous system, specifically the brain's motor-control circuitry (the basal ganglia and its connections).

Subspecialty fellowship of Neurology.

The 30-second version

Movement disorders is the corner of neurology you diagnose with your eyes. A patient walks across the room, holds their hands out, taps a finger, and from the pattern of the movement alone, the movement specialist names the disorder: the asymmetric pill-rolling tremor and stooped shuffle of Parkinson's, the twisting pull of a dystonia, the fast dance of chorea, the rhythmic postural tremor of essential tremor. Most of these conditions have no confirmatory blood test and no defining MRI finding, so the trained eye is the test, one of the most purely observational, "look-and-know" crafts left in medicine. The anchor disease is Parkinson's, but the clinic runs much wider (atypical parkinsonism, tremor, dystonia, Huntington's, tics, ataxia, functional movement disorders), and the work is quietly procedural: botulinum-toxin injection and deep-brain-stimulation (DBS) programming give it a satisfying hands-on garnish without an OR. The trade at the center of the field: one of the most humane, controllable, low-call lifestyles in all of neurology and a genuine therapeutic renaissance to work in, bought with the slow emotional weight of watching neurodegenerative disease advance over years, pay that sits at the bottom of neurology's subspecialties, and a fellowship that, uniquely, grants no board certification at all.

Quick dashboard (details and sources below)
Training after med school 5–6 years (PGY-1 intern year + 3 yr neurology + 1–2 yr fellowship)
Total from college start ~13–14 years (4 undergrad + 4 med school + 4 neurology residency + 1–2 fellowship)
Training chain Med school (4) → PGY-1 intern year → 3 yr Neurology → 1–2 yr Movement Disorders fellowship
Competitiveness (as a Movement Disorders fellowship) Low — non-ACGME, no board exam; ~25% of positions go unfilled ⟳
Typical full-time pay ~$240,000–$290,000 total comp — at or below general neurology, the low end of the field ⟳
Pay vs. general neurology AMN 2025 movement avg $240,000 vs. general $244,000 (AMN) / $309,882 median (AAN) — a discount, not a premium ⟳
Lifestyle Outpatient, daytime, minimal acute/overnight call — one of neurology's most controllable
Burnout Inherits neurology (~44%, sources vary) minus the call load, plus a real emotional/decline load ⟳
% women No subspecialty figure — inherit neurology (33% practicing, 50.2% residents) ⟳
DO / IMG accessibility Open at the fellowship, which is undersubscribed and non-board; the parent runs 18.8% DO and 22.4% IMG of its filled PGY-1 positions ⟳

What they actually do

Movement disorders neurologists diagnose and manage diseases that make the body move too much (hyperkinetic) or too little (hypokinetic): the tremors, stiffness, involuntary movements, and gait failures that arise from dysfunction in the brain's motor-control circuitry, chiefly the basal ganglia and its connections. The anchor disease is Parkinson's disease, but the clinic is far broader: atypical parkinsonism (progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration), essential tremor, dystonia (cervical dystonia, blepharospasm, writer's cramp, generalized/genetic dystonias), Huntington's disease, tics and Tourette syndrome, ataxias, myoclonus, restless legs, chorea, and functional (psychogenic) movement disorders.12

The defining clinical skill is phenomenology, the trained eye that watches a patient walk, hold out their hands, and perform maneuvers, and from the pattern of abnormal movement alone names the disorder, often before (or entirely without) a scan, because most of these conditions have no confirmatory blood test or MRI finding. It is one of the most visually diagnostic, "look-and-know" corners of all of medicine, and it's often called the most classical of the neurology subspecialties, the localization-and-observation art that drew many people to neurology in the first place, concentrated into a single clinic. The work is overwhelmingly outpatient and deeply longitudinal: you follow the same Parkinson's or Huntington's patient for a decade-plus, titrating medications and devices as a neurodegenerative disease slowly advances, which is why the field carries a real, sustained emotional weight even as it sits among neurology's most therapeutically active subspecialties.12

What separates movement disorders from purely cognitive neurology is that it is quietly procedural. Two signature hands-on skills, botulinum-toxin injection and DBS programming, plus a growing role in MR-guided focused ultrasound give it a real, satisfying procedural half without the OR or the cath lab.

Representative procedures and hands-on work (a light, high-yield procedural garnish rather than the OR): botulinum-toxin (Botox/BoNT) injection for dystonia (cervical dystonia, blepharospasm, limb/task-specific dystonia), spasticity, hemifacial spasm, and sialorrhea, often EMG- or ultrasound-guided · DBS patient selection and device programming, meaning evaluating candidacy (Parkinson's, essential tremor, dystonia) and post-operatively tuning the implanted pulse generator over many visits, while the neurosurgeon implants the device · MR-guided focused ultrasound (MRgFUS) candidacy, targeting input, and follow-up · DaTscan (dopamine-transporter SPECT) interpretation · standardized rating-scale exams (MDS-UPDRS, UHDRS, TETRAS, BFMDRS, TWSTRS, YGTSS) · genetic-testing interpretation and clinical-trial assessments.123

A day in the life (outpatient-heavy, the dominant mode): A full clinic day of scheduled visits: a newly diagnosed Parkinson's patient starting levodopa; several established Parkinson's patients whose motor fluctuations and dyskinesias need medication timing adjusted or a device therapy (pump/DBS) discussed; a cervical-dystonia patient in for a scheduled Botox injection session (a block of the day is often carved out as a dedicated injection clinic); a DBS programming visit where you sit with a tablet and methodically tune stimulation while watching a tremor or rigidity respond in real time; a tremor patient you're evaluating for focused-ultrasound candidacy; a functional movement disorder consult that needs a careful, compassionate explanation of a non-degenerative diagnosis; and a Huntington's or atypical-parkinsonism family navigating a hard prognosis. Interspersed: multidisciplinary DBS selection conferences with neurosurgery and neuropsychology, clinical-trial visits (the field is unusually trial-dense), and a lot of longitudinal call-backs and care coordination. Call is light. This is an outpatient, clinic-based subspecialty with little acute or overnight burden, the near-opposite of the stroke sibling.

The training path & time to completion

Medical school (4 yrs) → PGY-1 intern year → 3 years of adult neurology (PGY-2–PGY-4) → 1–2 year Movement Disorders fellowship → NO board exam / NO formal subspecialty certification (institution- and society-based training only).14

  • It's a fellowship, not a match-from-med-school residency. You first complete a full neurology residency (which itself begins with a broad PGY-1 intern year; see the parent neurology profile's "categorical vs. advanced" entry wrinkle), then add the movement disorders fellowship on top.14
  • Prerequisite residency: completion of an adult Neurology residency (US or Canadian). Movement disorders is also a recognized pathway after Child Neurology residency for those who want pediatric movement disorders (common across neuro fellowships, though entry rules vary by program). It is not open to non-neurologists.1
  • Fellowship length: 1 year minimum; commonly 1–2 years. Many academic programs offer or expect a second year for research, DBS/focused-ultrasound procedural depth, or an academic track. The AAN FAQ lists a 1-year full-time minimum.1
  • Accreditation: NONE / non-ACGME. Per the AAN fellowship FAQ, "This specialty is not accredited at this time." Fellowships are institution-based, and many voluntarily align their training with the curriculum of the International Parkinson and Movement Disorder Society (MDS), the field's governing society, but that's a society and program-level standard rather than accreditation.15
  • Board / certification: NONE. "There is no board in this specialty." There is no ABPN subspecialty exam and no UCNS certification in Movement Disorders, a sharp contrast with the sibling Vascular Neurology (ACGME-accredited 2003, ABPN board exam since 2005) and with UCNS-certified neuro fellowships like headache or behavioral neurology. A movement fellow remains board-certified in Neurology (ABPN) from residency; the fellowship adds expertise and hiring credibility but no additional certificate. The field's own program directors are split on whether it should ever pursue accreditation or a certifying exam (roughly evenly divided), blocked by program non-uniformity and funding. This matters, because it is the field's defining structural quirk.15
  • Application: no formal NRMP match for most of the field. Candidates apply directly to individual programs ~1 year ahead; the AAN FAQ describes an informal match of roughly 15 programs that make offers around October 1, with many other programs accepting applications year-round / rolling. (Unlike vascular neurology, which runs through the NRMP Specialties Matching Service.)1
  • Total from the start of college: ~13 years for the 1-year route (4 + 4 + 4 residency + 1), or ~14 years for a 2-year fellowship. General neurology is ~12 years.1
  • Is the fellowship required? Not legally, since general neurologists manage Parkinson's and tremor routinely, but the fellowship is effectively required to be a DBS-programming, Botox-injecting movement specialist, to run a movement/DBS center, to do academic movement work, or to be marketed as a "movement disorders specialist." Because there's no board, the fellowship itself, plus program reputation and MDS-aligned training, is the credential.1

How competitive is it?

As a fellowship, movement disorders is not competitive to enter, because the bottleneck is applicant interest rather than selectivity. Like vascular neurology, this is a shortage subspecialty that actively recruits; unlike vascular neurology, it has no accreditation and no board gate at all.

  • No centralized match, so no clean annual data. There is no NRMP/SF Match for most of the field. Roughly 15 programs run an informal match with an October 1 decision date, and the rest accept rolling, year-round applications. That means there is no clean fill-rate, applicant-to-position ratio, or US-MD/DO/IMG matched-composition table the way vascular neurology has. Honestly: limited data.1
  • Best available longitudinal data, the MDS workforce survey. Program/position counts and fill:6 ⟳
    • 2012: 29 programs · 43 positions · 34 filled → 79% fill.
    • 2020: 52 programs · 72 positions · 54 filled → 75% fill, meaning roughly one-fourth of movement fellowship positions went unfilled, even as Parkinson's disease affects ~1 million Americans. The authors frame this explicitly as a workforce shortage / undersubscription.
  • Composition of who enters: limited data. No matched-composition breakdown exists (no central match). Reason from the parent field: neurology takes DO and international graduates at roughly the ordinary PGY-1 rate, and an undersubscribed, non-board fellowship is generally more open still (see Demographics and the FLI angle).
  • The honest read: for a qualified neurology resident who wants movement disorders, this is broadly attainable. The field has more training slots than takers and no certification gatekeeping. The competitive question here is whether the extra year is worth it when it pays at or below general neurology and hands you no board credential, a genuinely different conversation (see Compensation and Culture).16

Board: none. There is no ABPN or UCNS movement-disorders certification. The fellow's certificate remains ABPN Neurology from residency.1

Compensation — the robust version

Here is the fact that reframes the whole field: movement disorders pays at or below general neurology, the low end of the entire specialty, despite being procedural. The fellowship year buys skill and access rather than a raise. Always read these numbers against general neurology, because that's the real comparison a movement fellowship is competing with, and the counterintuitive headline is that a procedural subspecialty lands near the bottom of neurology pay.

Primary movement-specific anchor, the AMN Healthcare Neurologist Salary Report 2025:7 ⟳

  • Movement Disorders average total comp: $240,000 (starting ~$190,000).
  • In AMN's own apples-to-apples subspecialty set, that's near the bottom: Neuro-Oncology ~$341,000 · Neuro-Critical Care ~$270,000 · Multiple Sclerosis ~$267,000 · General Neurology $244,000 · Movement Disorders $240,000 · Pediatric/Child Neurology $225,000–$250,000. So movement disorders sits **$4k below general neurology and above only pediatric neurology, a discount rather than a premium.**

The "vs. general neurology" comparison on the bigger survey. The AAN 2025 Neurology Compensation & Productivity survey has no standalone movement-disorders line (its subspecialty medians run Vascular $315,913 · General $309,882 · Epilepsy $282,386 · Child $256,082), so AMN is the primary movement-specific figure. Read against AAN's general-neurology median of $309,882, movement disorders clearly sits at the low end.8 ⟳

Higher and lower benchmarks (surveys measure different things, so reconcile rather than averaging blindly):

  • ZipRecruiter (2026): "Movement Disorder Neurologist" average $293,223/yr ($141/hr), 25th–75th percentile $230,000–$392,000, a crowdsourced aggregator that pools broadly and title-matches, so it runs above the AMN survey; treat it as a soft upper anchor rather than a survey.9 ⟳
  • SalaryDr (2026): median $425,000, but from n = 8 self-reported submissions. Disregard as an unreliable tiny-sample outlier (implausibly above general neurology and every survey), the same way the sibling profile flagged its crowdsourced noise.10 ⟳
  • A defensible "typical full-time" figure for 2025–26 is ~$240,000–$290,000 total comp. Centered on the AMN $240k for a movement-focused academic/clinic practice, drifting toward general-neurology numbers (~$300k+) for those who carry general/inpatient neurology alongside a movement clinic. ⟳

Why there's no procedural premium (the honest through-line). Premeds assume Botox + DBS = procedural money. It doesn't land that way, for three stacking reasons:27

  • The high-margin procedures belong to neurosurgery. The movement neurologist selects and programs DBS, but the neurosurgeon implants it and captures the large surgical fee. MR-guided focused ultrasound is the same story: the movement specialist does candidacy, targeting input, and follow-up, the ablation is billed as a neurosurgical/interventional procedure. This is the exact split-economics pattern as stroke (the vascular neurologist decides, the neurointerventionalist earns the procedure).
  • The practice is E/M-heavy, long-visit cognitive care. A new-Parkinson's or complex-dystonia evaluation is a lengthy history and detailed exam with rating scales; you see fewer patients per session than a headache or general clinic. That's clinically rewarding but caps volume-based revenue. Botox and DBS programming do generate solid, efficient RVUs, but not enough to lift the average.
  • It concentrates in lower-paying academic settings. DBS and focused-ultrasound centers are academic and tertiary-referral, and academic neurology pays the least (AAN academic median ~$277k against hospital-based ~$362,500), which structurally pulls the field's average toward the low end.8

By setting, which matters far more than the subspecialty label. No movement-specific setting table exists (limited data); inherit the parent/AAN pattern, where private/community practice pays far more than academic. Community sentiment repeatedly makes the same point: academic movement salaries are commonly cited around ~$180k while private/community movement jobs run ~$250k–$350k, a spread driven by setting rather than by the subspecialty. A procedurally busy community Botox/DBS practice narrows the gap with general neurology; a pure academic role widens it.811 ⟳

Geography (inherit from parent neurology; no movement-specific table exists, so limited data): Midwest/South, non-coastal, and underserved markets pay a premium to overcome the neurologist shortage, while saturated high-cost coastal metros pay less nominally. ZipRecruiter's "top-paying counties" reflect crowdsourced noise rather than a reliable geographic signal.89 ⟳

How you're actually paid. Largely fixed salary plus a wRVU incentive, like parent neurology (~34% have wRVU-set base pay; ~65% are incentive-eligible). The movement-specific revenue lines, botulinum-toxin chemodenervation (billable injection codes plus the toxin J-code, a genuine recurring in-office stream and the field's main procedural earner) and DBS programming encounters, are real and efficient, but modest against the volume ceiling of long cognitive visits.7

Trend: demand is solid and growing (aging population, expanding DBS and focused-ultrasound programs), and the therapy side is booming (see Wellbeing and Fun facts), but none of that has translated into a pay premium, because the base tracks general neurology and the high-margin procedures sit next door in neurosurgery. Mirror the sibling framing: in stroke, "the fellowship buys ~2%; the catheter buys 2–3×." Here the fellowship buys nothing on base pay. Botox and DBS-programming revenue are real but modest, and the honest reason to do it is the work rather than the wage.78

Lifestyle

Movement disorders is one of the most lifestyle-controllable corners of neurology, the near-opposite of its stroke sibling. Where vascular neurology's defining variable is brutal acute overnight call, movement disorders is defined by the absence of it. It is overwhelmingly outpatient, clinic-based, scheduled, and daytime. Tellingly, the AAN fellowship FAQ, which details call burden for the acute neuro fellowships, provides no call-schedule detail for movement disorders, because there is essentially no acute call intrinsic to the subspecialty.1

  • Hours sit broadly in the general-neurology band but skewed to the controllable end, at roughly 40–50 clinical hours/week for a typical outpatient movement practice, largely within clinic hours.2
  • Call burden is the defining low variable. Little-to-no acute or overnight call is intrinsic to the field. True movement emergencies (neuroleptic malignant syndrome, status dystonicus, acute DBS hardware failure) exist but are rare rather than a nightly pager burden. Most movement neurologists carry only whatever general neurology call their group requires as a group citizen, not a movement-specific overnight load. In a pure movement/academic role, nights and weekends are largely protected. This is a real, sought-after feature and a common reason neurologists pick the field. (Contrast: neurointerventional/stroke carries the heaviest call in neurology; headache and movement carry the lightest.)12
  • Schedule control is high, with a texture caveat. Clinic is predictable, elective, and referral-driven, so it's easy to build a 4-day week, protect research/admin time, or wind down late-career. The caveat is intensity rather than hours: movement visits are long and cognitively dense, since a new-Parkinson's or complex-dystonia evaluation is a lengthy exam with formal rating scales, and DBS programming is time-consuming. You see fewer patients per session (pleasant clinically, but it depresses volume-based revenue; see Compensation). The procedural half (Botox clinics, DBS programming) is efficient and satisfying, in short, high-yield 10–20-minute encounters.2
  • Predictability: high, and telehealth-friendly for follow-ups (medication titration, non-motor symptom management), which adds real flexibility.

Lifestyle rating: 4/5. Genuinely one of the more controllable neurology subspecialties: outpatient, daytime, minimal acute/overnight call, telehealth-adaptable, elective and referral-based. It loses the fifth point to the cognitive/emotional density of long neurodegenerative visits and to the general-neurology group call most community jobs still fold in. That's a notch better than parent neurology's 3/5 and dramatically better than the stroke sibling's call-heavy 3/5.

Wellbeing — the part to take seriously

Burnout. No stand-alone "movement disorders burnout %" exists (limited data), so read two signals together. First, the parent field: Medscape 2024 put neurology at ~44% (lower-middle of all specialties), though field-synthesis reporting often places it higher (~48–55%); sources genuinely disagree, so don't quote one as settled.12 ⟳ Second, the subspecialty modifier cuts downward on the hours and call axis, since there's no measured overnight-call burnout driver like the one documented in vascular neurology (where 46% of stroke-call-takers said call contributed to their burnout), and upward on the emotional axis. Net read: likely at or modestly below baseline neurology, with the distress that does exist driven by emotional load and the administrative grind rather than clock time or sleep loss.12

Emotional load is the genuine weight of this field, and it's distinctive. This is the honest counterweight to the great lifestyle. Movement disorders is deeply longitudinal. You follow the same Parkinson's, Huntington's, or atypical-parkinsonism patient for years, often to the end. The relationships are a profound source of meaning (a recurring "why I love it"), but the emotional arc is heavy: much of the panel is progressive, incurable neurodegeneration. The atypical parkinsonisms (PSP, MSA, CBD) carry especially grim, fast trajectories; Huntington's carries genetic and family weight plus psychiatric burden; advanced Parkinson's brings dementia, falls, and psychosis. You also carry caregiver burden, the documented toll on the families you counsel. The reward is that symptomatic wins are real and sometimes dramatic: a well-programmed DBS or a good levodopa response can visibly restore function, Botox visibly relieves a disabling dystonia. So the emotional profile is "slow-motion loss punctuated by real symptomatic saves" rather than the acute life-and-death swings of stroke.2

Happiness and would-choose-again. There is no movement-specific figure, and no current all-physician one either. Nobody has published a would-choose-again rate broken out by specialty since about 2019, there is no current overall anchor, and this page used to give one at ~78%. It has been removed and nothing replaces it.13 ⟳ Parent neurology has been reported among the least happy outside work, at ~54%, driven by cognitive, administrative, and emotional load, though that table is unverified and should be read as such.13 Movement disorders removes the sleep-disruption tax that vascular neurology adds, which should help "outside work" happiness relative to stroke. Community sentiment skews genuinely positive on fit and meaning (people who choose it tend to love it) while clear-eyed that the pay is toward the low end (see Culture).1213

Career longevity is a genuine strength. Among the most sustainable neurology careers: low physical demand, no circadian/overnight toll, telehealth-friendly, and procedurally light (Botox and DBS programming are low-strain, not OR-intensive). The limiter is emotional and compassion fatigue from cumulative neurodegenerative decline, the opposite limiter from stroke, where the body-clock is the constraint. It's easy to taper into a 3–4-day clinic or a research/consultative role late-career; this is a field you can practice into your 70s.2

Who's in the field (demographics)

Fellowship-specific demographic breakdowns for movement disorders do not exist. There's no central match, so there's no matched-composition table, and parent-field reference data is the best available.

  • Women: no published movement-specific figure (limited data). Inherit parent neurology: 33% of practicing neurologists are women (AAMC, 2022 data), below the 38.7% all-physician average, and 50.2% of neurology residents are (ACGME, AY2024-25), so the pipeline is at parity even though the workforce is not.1412 ⟳ Movement disorders is outpatient, clinic-heavy, and light on call, a profile that tends to skew less male than the acute subspecialties, but ACGME accredits no movement-disorders fellowship and so counts none, and the AAMC workforce table covers only specialties with more than 2,500 active physicians. Neither has a row to read. ⟳
  • DO: no movement-specific figure. Inherit parent neurology, at 18.8% DO of the PGY-1 positions that filled in 2026, a little under the 21.5% across all PGY-1 positions. An undersubscribed, non-accredited, non-board fellowship is generally more open to DO grads rather than less.1512 ⟳
  • IMG: no movement-specific figure. Inherit parent neurology, at 22.4% IMG of the same filled positions, against 25.2% across all PGY-1 positions. An undersubscribed fellowship with no certification gate is a plausible credential-building path for IMG neurology grads, the same logic that makes vascular neurology ~38% IMG at the fellow level.1512 ⟳
  • URiM: no movement-specific data (limited data). Parent neurology is cited as having below-average URiM representation (Black and Hispanic/Latino physicians underrepresented relative to the US population), per AAMC workforce data and AAN diversity initiatives.12 ⟳

Culture, personality & the online stereotypes

Who gravitates here: neurologists who love the bedside exam as a craft and the pattern recognition of movement phenomenology, since the diagnosis here is unusually observational and visual (watching a gait, characterizing a tremor's frequency and context, spotting a subtle dystonic posture or a parkinsonian asymmetry). Online it's often called the most "classical neurology" of the subspecialties, the localization-and-observation art that drew many people to neurology, concentrated. It draws people who want deep, long-term relationships over acute episodes; who are patient, empathic, and comfortable with chronic incurable disease; who enjoy a light procedural garnish (Botox, DBS programming) without wanting the OR or the cath lab; and who value lifestyle control and a research/academic bent (the field is heavily academic and trial-rich, and Parkinson's is one of the most active therapeutic frontiers in medicine). As always, plenty of people in the field don't fit any of this.

The stereotypes. Community perception rather than fact. Each carries a kernel and an unfair edge, and plenty of people do not fit the mold:

  • "The gentle, cerebral, academic wing of neurology." The read online is that movement people are thoughtful, patient, relationship-oriented, and often academically inclined, "the old-school neurologist who still believes in the exam." Kernel of truth (it is exam- and observation-heavy and research-rich); the unfair edge is implying they're not procedural or "not busy," when Botox and DBS clinics are hands-on and full.
  • "The best lifestyle in neurology, with the paycheck to match." The perception is that you trade money for a controllable, call-light, humane schedule. Honestly stated: comp is toward the low end, and the lifestyle is controllable, but the "low pay" caricature ignores that Botox/DBS reimburse well and that private practice pays far more than the academic figure people quote.
  • "Married to the tuning fork. It's all Parkinson's." A dig that the field is narrow and slow. Reframe: the differential (atypical parkinsonism, dystonia, tremor, chorea, myoclonus, tics, ataxia, functional movement disorders) is one of neurology's richest, and functional/psychogenic movement disorders are a genuinely growing, intellectually demanding frontier.
  • "You picked the saddest patients." Overweights the neurodegenerative decline and ignores the real symptomatic wins (DBS, levodopa response, Botox relief) and the meaning of longitudinal care. Kernel of truth on the emotional load; unfair as a whole-field verdict.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, the loudest recurring theme is a positive "fit" story crossed with a blunt pay caveat. People who did the fellowship tend to describe deep satisfaction. They love the exam, the phenomenology, the long relationships, and the humane, call-light lifestyle, and repeatedly call the field "underrated" on quality of life. The universal caveat is money: broad agreement that movement disorders sits toward the low end of neurology comp, driven by long, low-volume visits and by the field's academic center of gravity, where you're paid by rank rather than procedure, and not by poor reimbursement per procedure, since Botox and DBS programming are efficient and pay well. A recurring nuance: setting matters more than the subspecialty label for income, and private and community jobs ($250k–$350k) far outpace academic ones (~$180k). The "is the fellowship worth it?" debate is gentler here than in vascular neurology: because there's no board exam and no ACGME credential, the fellowship's value is framed as skill and access (Botox competency, DBS programming, referral credibility, academic entry) rather than a certification, and some note a general neurologist can do meaningful movement work without it. Demand is described as solid and growing. Overall tone: content, mission-driven, unhurried, clear-eyed about the pay ceiling.1116

Voices from the field. Paraphrased from public writing, with links to the originals:

  • The Student Doctor Network "Movement Disorders Salary" thread lays out the economics candidly: academic movement salaries commonly cited ~$180k against private practice $250k–$350k, Botox and DBS programming reimburse well and are efficient, but long, detailed evaluations mean fewer patients per session and lower total volume than headache or neuromuscular; setting drives income more than the subspecialty itself.11
  • The AAN Movement Disorders Fellowship FAQ states plainly that the fellowship is ≥1 year, not ACGME-accredited, with "no board in this specialty," teaches Botox and DBS programming, and is entered via an informal ~15-program match plus rolling applications, pointing trainees to the Movement Disorder Society.1
  • The MDS-abstract program-director survey on accreditation and certification documents that the field has neither ACGME accreditation nor ABPN/UCNS certification, that program directors are roughly evenly split on whether to pursue them, and that program non-uniformity and funding are the barriers, the field's own internal debate over whether this fellowship should ever have a board exam.5

Why people choose it / why people leave

Why choose it: one of the most controllable, humane lifestyles in neurology, being outpatient, daytime, minimal on acute and overnight call, telehealth-adaptable, and sustainable into a long career · classical-neurology intellectual pleasure, with observational, exam-and-phenomenology-driven diagnosis across one of neurology's richest differentials · deep longitudinal relationships with patients and families over years · a light, satisfying procedural garnish (Botox, DBS programming) that's hands-on and well-reimbursed without the OR · a genuine therapeutic-growth story (expanding DBS, FDA-approved MR-guided focused ultrasound, new device/infusion therapies, a dense drug pipeline) · growing demand from an aging population and solid job security.

Why leave or avoid it: comp toward the low end of neurology (~$240k avg, AMN 2025; academic roles lower), since the fellowship year buys skill and access rather than a pay bump · no board exam or ACGME accreditation, so no portable credential to show for the year, and a general neurologist can do meaningful movement work without it · heavy emotional load, with a panel dominated by progressive, incurable neurodegeneration and the caregiver burden that comes with it; compassion fatigue is the real longevity limiter · low patient volume per session, since the long, dense visits that make the work rewarding also cap income in volume/RVU systems.

Best fit if: you love the neuro exam and the observational art of diagnosis · you want deep, long-term patient relationships over acute episodes · you value a controllable, call-light, daytime, sustainable schedule · you like a little procedural work (Botox, DBS) without the OR · you're drawn to an academic/research frontier · you can carry the emotional weight of chronic decline.

Not for you if: you want acute, adrenaline, fast fixes, or dramatic saves (look at stroke or neurocritical care) · you need high procedural income or a high pay ceiling · degenerative, incurable disease drains you · you want a formal board credential from your fellowship · you want high-throughput, short-visit clinic work.

The FLI angle — Movement Disorders for first-gen, low-income & immigrant students

Where it fits FLI realities well:

  • Reachable through the parent field, and unusually open as a fellowship. About 41% of neurology's PGY-1 positions went to DO and international graduates in 2026, close to the 46.7% those two groups took across all PGY-1 positions, so the parent is a normal-width door rather than a wide one. The movement fellowship itself is non-competitive and non-ACGME, entered through an informal ~15-program match plus year-round rolling applications, a structurally low-barrier path with no formal-match bottleneck. Because it's non-ACGME with no board exam, it's a realistic option for IMGs who can't otherwise enter certain accredited fellowships, and the absence of a certification gate lowers one barrier IMGs often hit. Visa and IMG policies vary by program, so check each one before you apply.115
  • Geographic and schedule flexibility. Outpatient, telehealth-adaptable, call-light work lets you live where family or status requires, stay near dependents, and build a stable, humane schedule, a concrete FLI advantage.2
  • PSLF fits naturally. Movement care concentrates in academic medical centers, VA Parkinson's centers (PADRECCs), and nonprofit specialty clinics, exactly the 501(c)(3) and government employers that qualify for Public Service Loan Forgiveness. A lower-salary but PSLF-eligible academic movement role can make the forgiveness math work well. (Ground it honestly: most physicians carry ~$200k+ in student debt; PSLF is real but paperwork-heavy rather than a guarantee.)
  • Career longevity means a long earning runway. Low physical and circadian toll means decades of sustainable practice, valuable when you're carrying debt and need a durable return.2

Risks to name honestly:

  • The extra year has arguably the weakest financial payoff in neurology. Movement disorders pays toward the low end (~$240k avg, AMN 2025; academic ~$180k in community reports) versus general neurology's ~$244k (AMN) to ~$309,882 median (AAN). For a first-gen or immigrant grad who needs to start earning and paying down debt fast, spending a fellowship year to enter a field that pays at or below general neurology, and hands you no board credential, is a real trade-off. Do it because you love the work rather than for money. The honest exception: private/community movement jobs pay far more than the academic figure ($250k–$350k), and Botox and DBS reimburse well, so a procedurally busy community practice narrows the gap.711
  • No credential to show for the year. With no ABPN/UCNS board and no ACGME accreditation, the fellowship's value is skill, referral credibility, and academic access rather than a portable certification. Weigh whether the (uncredentialed) skill-building justifies the deferred income.1
  • The emotional cost is a hidden tax. The neurodegenerative-decline load is heavy and cumulative, easy to underestimate from outside, and it's the main thing that wears people down here.2
  • IMG/visa specifics vary by program. The non-ACGME structure helps access, but confirm each program's visa sponsorship and that a non-accredited fellowship fits your licensure and immigration timeline before committing.

Bottom line: movement disorders is a reachable, humane subspecialty for DO, IMG, and first-gen neurology grads: low-barrier entry (non-ACGME, informal or rolling application), an outstanding controllable lifestyle, PSLF-friendly academic/VA employers, and a genuine research frontier. But be clear-eyed: it costs an extra year for little-to-no pay premium over general neurology and no board credential, and it carries a heavy emotional load. Choose it because you love the exam, the phenomenology, and the long relationships, rather than as a financial upgrade. Shadow a movement clinic, a DBS-programming session and a Botox session included, before you commit, and ask community vs. academic employers exactly how the procedures are compensated.

Sub-subspecialties & fellowships

Movement disorders is itself the fellowship, one or two years after neurology residency, and it sits outside the accredited system.

  • Non-ACGME, and no board exam. There is no subspecialty certificate to sit at the end. Competence is attested by the fellowship and by the practice you build.
  • Applications are informal and rolling. There is no match, which means timing and direct contact with programs matter more here than in the accredited pathways, and it is easy to be late without realizing it.
  • Deep brain stimulation programs are the differentiator. Whether your fellowship had one shapes the jobs open to you afterwards.

Fun facts

  • Movement disorders is one of the few subspecialties in medicine where the diagnosis is often made by watching the patient move. Many of its diseases have no confirmatory blood test or MRI, so the trained eye is the test.
  • It is a non-ACGME, non-board-certified fellowship, with literally no board exam in the field, a striking contrast with its ACGME/ABPN sibling, vascular neurology. The fellowship itself is the credential.
  • Deep brain stimulation splits neatly in two: the movement neurologist selects the candidate and programs the device over many visits, and the neurosurgeon implants it, the same "decide against operate" division as stroke's vascular-neurologist/neurointerventionalist split.
  • In February 2025, the FDA approved the first adaptive (closed-loop) DBS system for Parkinson's, letting stimulation adjust in real time to the brain's own signals, a whole new programming skill for the field.17
  • MR-guided focused ultrasound treats tremor incisionlessly, ablating a deep brain target with focused sound waves through an intact skull, and in 2025 expanded to bilateral treatment for advanced Parkinson's.18
  • VYALEV (foscarbidopa/foslevodopa), a 24-hour subcutaneous levodopa infusion pump, was FDA-approved in October 2024, part of a wave of advanced device and infusion therapies making late-stage Parkinson's care one of neurology's fastest-moving frontiers.19
  • The field is unusually trial-dense, with disease-modifying agents, gene therapies, and even repurposed GLP-1 drugs in active Parkinson's pipelines, so movement specialists are heavily involved in research.

Sources

Footnotes

  1. American Academy of Neurology — Movement Disorders Fellowship FAQs (Transitioning Resident resource): 1-year minimum full-time; prerequisite = completion of a US/Canadian Neurology residency; "This specialty is not accredited at this time"; "There is no board in this specialty" (no ABPN or UCNS exam); no formal match (direct application ~1 yr ahead; informal match ~15 programs deciding ~Oct 1, plus rolling year-round applications); training includes botulinum-toxin injection and DBS patient selection/programming; references the International Parkinson and Movement Disorder Society. https://www.aan.com/siteassets/home-page/tools-and-resources/resident--fellows/how-to-apply-for-a-fellowship/movement-disorders-fellowship-faq_tr.pdf (accessed 2026). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20

  2. Road to MD research synthesis, consistent with the neurology profile on this site — clinical scope (Parkinson's, atypical parkinsonism, tremor, dystonia, Huntington's, tics, ataxia, functional movement disorders), phenomenology-driven diagnosis, outpatient/longitudinal practice, light call, emotional load of neurodegeneration, career longevity, and lifestyle. 2026. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12

  3. Baylor College of Medicine — Movement Disorders Fellowship Curriculum: outpatient-heavy training at a Parkinson's Disease Center & Movement Disorders Clinic; competency in rating scales (MDS-UPDRS, UHDRS, TETRAS, BFMDRS, TWSTRS, YGTSS); botulinum-toxin injection and DBS programming; pediatric cases; research/clinical-trial emphasis; pre/post-op DBS assessments. https://www.bcm.edu/departments/neurology/education/movement-disorders-fellowship/curriculum (accessed 2026). ↩

  4. See the neurology profile on this site — training structure (PGY-1 intern year + 3-year neurology residency; categorical vs. advanced entry), ABPN neurology board, and the subspecialty accreditation landscape (ACGME vs. UCNS vs. non-accredited), which lists Movement Disorders as a 1–2 yr non-accredited fellowship with Botox/DBS. That is a cross-reference rather than a source; the accreditation and board status of this fellowship are documented at 1. 2026. ↩ ↩2

  5. MDS Abstracts — "The Accreditation and Certification of the Movement Disorders Subspecialty" (program-director survey): the field has neither ACGME accreditation nor ABPN/UCNS certification; program directors are roughly evenly split on pursuing accreditation (~48%) vs. a certifying exam (~52%); program non-uniformity and funding cited as barriers; many programs voluntarily follow the MDS curriculum. https://www.mdsabstracts.org/abstract/the-accreditation-and-certification-of-the-movement-disorders-subspecialty/ (accessed 2026). ↩ ↩2 ↩3

  6. Ali F. et al., "Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs," MDS Abstracts (2020 data): 2012 — 29 programs/43 positions/34 filled (79%); 2020 — 52 programs/72 positions/54 filled (75%), i.e., ~one-fourth of positions unfilled; documents a workforce shortage/undersubscription. https://www.mdsabstracts.org/abstract/movement-disorder-fellowships-assessment-and-recruitment-strategies-to-meet-clinical-needs/ (2020). ⟳ ↩ ↩2

  7. AMN Healthcare — Neurologist Salary Report 2025 (updated 2025-09-30): Movement Disorders average ~$240,000 (starting ~$190,000); subspecialty set — Neuro-Oncology ~$341,000, Neuro-Critical Care ~$270,000, MS ~$267,000, General Neurology ~$244,000, Movement Disorders ~$240,000, Pediatric/Child ~$225,000–$250,000. https://www.amnhealthcare.com/blog/physician/perm/neurologist-salary-report-2025/ (2025). ⟳ ↩ ↩2 ↩3 ↩4 ↩5

  8. AAN 2025 Neurology Compensation & Productivity survey (2024 data) via parent profile and Barton Associates Neurologist Salary Guide 2026 — general-neurology median $309,882; subspecialty medians Vascular $315,913, Epilepsy $282,386, Child $256,082 (no standalone movement-disorders line); by-setting medians hospital-based $362,500, multispecialty $350,000, neurology group $315,489, solo $300,000, academic $277,288, government $255,000. https://www.bartonassociates.com/neurologist-salary-guide/ (2026); AAN executive summary https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist--administrators/benchmarking-data/neurology-compensation--productivity/25-ncp-executive-summary.pdf (2025). ⟳ ↩ ↩2 ↩3 ↩4 ↩5

  9. ZipRecruiter — "Movement Disorder Neurologist" Salary (2026): average $293,223/yr ($141/hr); 25th–75th percentile $230,000–$392,000. Crowdsourced aggregator that title-matches and pools broadly — treat as a soft upper anchor, not a survey. https://www.ziprecruiter.com/Salaries/Movement-Disorder-Neurologist-Salary (2026). ⟳ ↩ ↩2

  10. SalaryDr — Movement Disorders Neurologist (2026): median ~$425,000 from n = 8 self-reported submissions — an unreliable tiny-sample outlier; disregard. https://www.salarydr.com/specialty/neurology/movement-disorders (2026). ⟳ ↩

  11. Student Doctor Network forum, "Movement Disorders Salary" thread — paraphrased community sentiment: academic movement salaries commonly cited ~$180k (range ~$150k–$220k) vs. private practice $250k–$350k; Botox and DBS programming reimburse well and are efficient (10–20 min) but long, detailed evaluations mean fewer patients per session and lower total volume than headache/neuromuscular/pain; setting (academic vs. private) drives income more than the subspecialty itself. https://forums.studentdoctor.net/threads/movement-disorders-salary.1367077/ (accessed 2026). ↩ ↩2 ↩3 ↩4

  12. Cross-specialty figures for parent neurology. Women in practice, 33%: AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america. Women in training: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf, which puts neurology residents at 50.2% women. Corrected 2026-08-13 from the ~40% this page carried, ten points low. The 38.7% all-physician average is unchanged and remains the right comparison for neurology's 33%. Table C.21 has no movement-disorders row, because the fellowship is not ACGME-accredited. Burnout 44%, against an all-physician average of 49%, with field-synthesis reporting often placing neurology higher at ~48–55%: Medscape Physician Burnout & Depression Report 2024, n=9,226, fielded July–October 2023, paywalled and returning HTTP 402, so it reaches this page through three independent relays that agree on the edition, the instrument and every row — Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). DO and IMG shares: NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf, which reports 18.8% DO and 22.4% IMG of neurology's filled PGY-1 positions in 2026. Those are the figures this page now carries; see 15 for the denominator and for the 2025 pair it replaced. The "least happy outside work ~54%" line is from a Medscape lifestyle table this site has flagged unverified; see 13. On URiM, no current race-and-ethnicity-by-specialty table is published anywhere, and AAMC's 2025 Key Findings gives the aggregate only (5.3% Black or African American, 6.7% Hispanic or Latino of active physicians in 2024, https://www.aamc.org/data-reports/data/2025-key-findings), so the "below-average" line is a directional read rather than a cited neurology figure. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  13. Would-choose-again and happiness anchors. There is no publisher for would-choose-again by specialty, and there is no current overall figure either. Medscape stopped breaking it out around 2019, and the most recent traceable datapoint of any kind is 68% among physicians under 40, from Medscape's 2022 Young Physician Compensation Report, which carries no specialty breakdown. This page previously gave "~78% of physicians would choose medicine again (Medscape secondary)." That number has no source and has been removed rather than replaced. The neurology "least happy outside work ~54%" figure comes from a Medscape 2024 lifestyle table reported second-hand by HCN, which does not link the table it is reporting and which nobody here has opened. Unverified — do not treat as confirmed. No URL is given for it, because pointing a reader at a secondary that cannot show its own source would look like verification and would not be any. ⟳ ↩ ↩2 ↩3 ↩4

  14. AAMC, Physician Specialty Data Report / "Active Physicians by Sex and Specialty" (2021 data) and "Women are changing the face of medicine" (2022) — neurology 33% women practicing; all-physician average 38.7%, which is the figure this page compares against and is not neurology's own. https://web.archive.org/web/20250112142220/https://www.aamc.org/data-reports/workforce/data/active-physicians-sex-specialty-2021 (2021/2022). ⟳ ↩

  15. Parent-field DO and IMG composition, applied here to reason about an undersubscribed, non-board fellowship's openness, because no movement-specific matched-composition data exists. NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf — neurology offered 1,003 PGY-1 positions and filled 999, taking 583 US MD seniors, 4 MD graduates, 181 DO seniors, 7 DO graduates, 49 US IMGs and 175 non-US IMGs, so 18.8% DO (188 of 999) and 22.4% IMG (224 of 999) on the positions-filled denominator. The same table's all-PGY-1 totals row gives 21.5% DO and 25.2% IMG of 38,354 filled positions, and 46.7% for the two groups together. Swept 2026-08-17: the demographics section carried ~16.5% DO and ~29% IMG from the 2025 report, a pair that was internally inconsistent as well as a cycle old — 16.5% was DO seniors alone over positions offered (154 of 932) while ~29% counted both IMG types. On one denominator the two cycles read DO 17.0% → 18.8% and IMG 29.1% → 22.4%. The FLI section's "one of the more DO- and IMG-open specialties" and its "nearly half" both went with the number: the real figure is about 41%, and it is slightly below the all-class 46.7%. Value swept: 18.8% DO and 22.4% IMG, denominator positions filled, source NRMP Main Match 2026 Table 2. ⟳ ↩ ↩2 ↩3 ↩4

  16. Movement disorders lifestyle, wellbeing, and culture — synthesized from paraphrased Reddit (r/Neurology, r/medicalschool)/SDN sentiment and Doximity/KevinMD physician writing: controllable outpatient/low-call lifestyle, deep longitudinal relationships, the emotional weight of neurodegeneration, the "underrated quality of life, low-end pay" consensus, and the gentler "is the fellowship worth it?" debate. reddit.com; studentdoctor.net; opmed.doximity.com; kevinmd.com. (Sentiment synthesized and attributed to community perception; no verbatim quotes.) 2026. ↩

  17. Medtronic — "Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's," Feb 24, 2025 (closed-loop/adaptive DBS — BrainSense aDBS). https://news.medtronic.com/2025-02-24-Medtronic-earns-U-S-FDA-approval-for-the-worlds-first-Adaptive-deep-brain-stimulation-system-for-people-with-Parkinsons (2025). ↩

  18. Focused Ultrasound Foundation — "FDA Approves Bilateral Focused Ultrasound Treatment for Parkinson's Disease" (2025), and Lancet Neurology (2025) review of MR-guided focused ultrasound for movement disorders (incisionless thalamotomy for essential tremor and Parkinson's tremor; expanding indications). https://www.fusfoundation.org/posts/fda-approves-bilateral-focused-ultrasound-treatment-for-parkinsons-disease/ ; https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00210-8/abstract (2025). ↩

  19. AbbVie — "U.S. FDA Approves VYALEV (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease," Oct 17, 2024 (24-hour subcutaneous levodopa infusion pump). https://news.abbvie.com/2024-10-17-U-S-FDA-Approves-VYALEV-TM-foscarbidopa-and-foslevodopa-for-Adults-Living-with-Advanced-Parkinsons-Disease (2024). ↩

Researched with AI assistance and reviewed by hand. How this site is made